RxDoctor Payments Data

Sally Kangas

Adult Health · Edina, MNNPI 1225466840

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,013 of the $1,143 with a category attached, or 88.6%. Medtronic accounts for 79.5% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $767, 3.4 times the $223 reported in 2021.

$1,143in general payments, 2019–2025

Across 18 payments — averaging $63.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$909
  • Boston Scientific$108
  • Relievant Medsystems, Inc.$65
  • Vertos Medical, Inc.$28
  • Hikma Pharmaceuticals USA$21
  • Nevro Corp.$12

What the payments were for

  • Travel & lodging$11010%
  • Food & beverage$1,01389%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,143 in reported general payments places this provider in the 85th percentile of 233 adult health providers in Minnesota.

See all adult health providers in Minnesota

Medicare billing

Part B allowed, 2024
$151,336
Medicare patients
160
Services billed
1,539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl102$61,060
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen537$22,732
Oxycodone Hcl871$18,325
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl76$17,050
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen421$11,353
SavellaMilnacipran Hcl19$10,755
Hydrocodone Bitartrate ErHydrocodone Bitartrate18$9,148
Morphine Sulfate ErMorphine Sulfate337$9,095
Gabapentin297$8,753
Hydromorphone ErHydromorphone Hcl13$7,405
LinzessLinaclotide12$6,333
Tizanidine Hcl158$5,351
Fentanyl66$5,019
Lidocaine22$4,691
Methocarbamol100$2,007

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl$21$19,429150 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 233 adult health providers in Minnesota.

Other adult health in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →